{"schema_version":"secwatch.filing_event.v1","accession":"0001725160-23-000178","form_type":"8-K","ticker":"ZNTL","cik":"0001725160","company_name":"Zentalis Pharmaceuticals, Inc.","filed_at":"2023-10-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.195906+00:00","generated_at":"2026-06-10T03:31:47.104303+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Zentalis Pharmaceuticals COO Iris Roth departs effective Oct 10, 2023","bullets":["Dr. Iris Roth ceases as COO at 11:59 p.m. ET on Oct 10, 2023.","Company expects to provide severance benefits per Employment Agreement dated Feb 8, 2023.","No replacement or additional details on departure reason provided."],"urls":{"canonical":"https://secwatch.observer/filing/0001725160-23-000178","json":"https://secwatch.observer/filing/0001725160-23-000178.json","markdown":"https://secwatch.observer/filing/0001725160-23-000178.md","text":"https://secwatch.observer/filing/0001725160-23-000178.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1725160/000172516023000178/0001725160-23-000178-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1725160/000172516023000178/zntl-20231006.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T03:31:47.104303+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"74ed8b4cab","claim":"Iris Roth departed as Chief Operating Officer at Zentalis Pharmaceuticals, Inc..","evidence_excerpt":"On Friday, October 6, 2023, Zentalis Pharmaceuticals, Inc. (the “Company”) announced that Iris Roth, Ph.D., Chief Operating Officer of the Company, will depart from the Company and cease serving as Chief Operating Officer of the Company, effective as of 11:59 p.m. Eastern Time on Tuesday, October 10, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516023000178/0001725160-23-000178-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"depart"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}